Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 2]
Phase 2 trial of Hu3S193 as consolidation therapy for women with ovarian, fallopian tube, or primary peritoneal cancer; the study is termina…
-
CLINICAL_TRIALS trial_result · 2016-12-19Clinical Trial Update: S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
A phase 2 trial evaluated docetaxel with or without vandetanib in patients with persistent or recurrent ovarian epithelial cancer, fallopian…
-
CLINICAL_TRIALS trial_result · 2016-12-19Clinical Trial Update: First-line Intraperitoneal Cisplatin and Etoposide Chemotherapy for Ovarian Cancer [Phase 2]
A Phase 2 study evaluating first-line intraperitoneal cisplatin and etoposide for bulky stage IIIC/IV epithelial ovarian cancer and related …
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer [Phase 3]
This update reports the completion of the TRINOVA-1 Phase 3 trial evaluating AMG 386 in combination with weekly paclitaxel for fallopian tub…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer. [Phase 1]
Phase I study of alemtuzumab in relapsed ovarian cancer and primary peritoneal cancer was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer [Phase 2]
Phase 2 trial of regorafenib in recurrent ovarian, primary peritoneal, and fallopian tube cancer was terminated with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer [NA]
A completed clinical trial evaluating whether a low-fiber or high-fiber diet reduces bowel-related side effects in patients undergoing radia…
-
CLINICAL_TRIALS trial_result · 2016-10-24Clinical Trial Update: Accelerating Gastrointestinal Recovery [Phase 3]
Phase 3 trial completed evaluating acceleration of gastrointestinal recovery in patients with ovarian cancer, fallopian tube cancer, and per…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial of vorinostat with carboplatin and gemcitabine in women with recurrent, platinum-sensitive ovarian cancer; study te…
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers [Phase 1]
Phase 1 study evaluating MM-121 in combination with paclitaxel in patients with advanced gynecologic cancers and HER2-non-overexpressing bre…
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206 [Phase 2]
Phase 2 Japanese trial (JCOG0206) evaluating chemotherapy followed by cytoreductive surgery for ovarian, fallopian tube, and peritoneal canc…
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer [Phase 2]
A phase 2 study evaluating the combination of RAD001 (everolimus) and bevacizumab in recurrent ovarian, fallopian tube, and primary peritone…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: Tivozanib As Maintenance Therapy In GYN [Phase 2]
Phase 2 trial evaluating tivozanib as maintenance therapy in gynecologic cancers was terminated, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: Viral Therapy in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Did Not Respond to Platinum Chemotherapy [Phase 1]
A Phase 1 trial of a viral therapy in patients with recurrent fallopian tube cancer, recurrent ovarian cancer, or recurrent primary peritone…
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Search for Predictors of Therapeutic Response in Ovarian Carcinoma [NA]
Completed clinical trial at Centre François Baclesse investigating predictors of therapeutic response in ovarian carcinoma and related fallo…
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer [Phase 3]
Phase III trial OVATURE comparing weekly carboplatin with and without phenoxodiol in platinum-resistant recurrent epithelial ovarian cancer …
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
A completed Phase 1/Phase 2 study evaluating phenoxodiol in combination with cisplatin or paclitaxel for recurrent ovarian epithelial, fallo…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis [Phase 3]
Phase 3 trial evaluating octreotide to prevent diarrhea in patients receiving pelvic radiotherapy across multiple pelvic cancers has complet…
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]
Phase II trial results for MK-2206, an Akt inhibitor, in recurrent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer …
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer [Phase 1]
Phase 1 trial evaluating UCN-01 in combination with topotecan in patients with recurrent ovarian epithelial cancer, fallopian tube cancer, o…
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Phase II ABT-888 With Cyclophosphamide [Phase 2]
Phase II trial evaluating veliparib (ABT-888) in combination with cyclophosphamide across ovarian and related gynecologic cancers; results w…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies [Phase 2]
Phase 2 clinical trial evaluating sequential angiogenic blockade for recurrent Mullerian malignancies, completed with results posted in 2016…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers [Phase 2]
Phase 2 study evaluating MM-121 (seribantumab) in combination with paclitaxel for platinum-resistant/refractory advanced ovarian, fallopian …
-
CLINICAL_TRIALS trial_result · 2016-04-05Clinical Trial Update: Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane [Phase 3]
A Phase 3 trial comparing chemotherapy versus hormonal treatment in platinum-resistant ovarian cancer (including peritoneal and fallopian tu…
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract [Phase 2]
A Phase 2 clinical trial evaluating a combination chemotherapy regimen in women with endometrial cancer, fallopian tube cancer, ovarian canc…